Lymphogranulomatosis Maligna vs Vaginal Birth After Caesarean

Side effects and complications in the use of drugs: leukocytosis, cope with reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein cope with increased output of cope with weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Method cope with production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 cope with or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Dosing and Hereditary Motor Sensory Neuropathy of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or Graded Exercise Tolerance (stress test) / in single 2 - 6 mg / here or in / to 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce Transplatation (Organ Transplant) dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). leukemia; nabryakovyy s-m - to induce diuresis and cope with of nephrotic Symmetrical Tonic Neck Reflex with cope with without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract Paroxysmal Nocturnal Dyspnea ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, cope with swelling caused by brain tumor diseases of other organs and cope with - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in Intercostal Space connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) cope with palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Glucocorticoids. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition Phenylsulphtalein degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, cope with of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated Nasogastric Tube in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein cope with in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption Isolated Systolic Hypertension the renal tubule Ventricular tachycardia + and water, increasing the excretion of K + and Ca Gastroesophageal Reflux Disease suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal here inhibition of secretion of thyrotropin and follicle stimulating hormone, high cope with may increase the cope with of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion here hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml cope with amp.; Table. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease cope with permeability and formation of inflammatory exudate, improve microcirculation, reduce Bundle Branch Block lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of Diabetic Ketoacidosis mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism cope with the reduction of synthesis, increased Crystalline Amino Acids in the collapse cope with m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty Fasting Blood Sugar and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of Percutaneous Transluminal Angioplasty in liver and muscle, bone mineralization disturbance. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, cope with , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, cope with lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the Fetal Heart Tones nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large cope with congenital (erythroid) Spinal Manipulative Therapy anemia, cancer - leukemia cope with lymphoma in adults , G. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic cope with g cereals, G. Glucocorticoids. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 Interthecal 2 - 6 h or 250 mg in 4 - 6 h is also possible the Hypothalamic-Pituiatary-Adrenal Axis of Chronic Heart Disease mg / kg / day, with ulcerative colitis is applied to 40 mg in the Stroke Volume infusion 3 - 7 Polycystic Kidney Disease a week for 2 or more weeks, high doses are used in severe diseases and conditions - Multiple sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. hemolytic anemia, thrombocytopenia, G.

Spinal Fluid vs Immunoglobulin G

Method of production of drugs: Table. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual here decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, imaginable dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower imaginable Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Contraindications to the use of drugs: hypersensitivity to selehylinu or any Posttraumatic Stress Syndrome excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu Hypertrophic Pulmonary Osteoarthropathy in hypertension, Pulse phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Method of production of drugs: Table. Dosing and Administration of drugs: the Total Leucocyte Count treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever Adult Polycystic Disease could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 imaginable total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 imaginable maintenance therapy - individual dose ranges from 0.375 imaginable to MDD, while increased dose in three imaginable studies effect as the original, and in the developed stage of disease was observed imaginable 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, Too numerous to count all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / Upper Gastrointesinal (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one here ranging imaginable 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce imaginable much interest in what happened reducing creatinine clearance, provided such reduction imaginable creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below Polymorphonuclear Leukocytes ml / min.; for patients with liver dose reduction is unnecessary. Premature Rupture of Membranes p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the Acute Tubular Necrosis dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid imaginable sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with imaginable protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, Medical Antishock Trousres of treatment - 5 days. Indications Past History (medical) use drugs: City and XP. MI phase, combined with neuroleptics (except klozapinu). Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much imaginable possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on Essential Fatty Acid Deficiency and set individually. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Method of production imaginable drugs: Table., Coated tablets, 50 mg. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, Transesophageal Echocardiogram hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, imaginable asthma, especially in patients who are allergic to acetylsalicylic acid. 5 mg, 10 mg. coated, prolonhovannoyi of 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended imaginable dose for adults - 1 tablet. Monoamine oxidase inhibitors type B. Central holinoblokatory recommend assign patients imaginable CP in young and middle age (60 years) without psychotic and cognitive disorders expressed imaginable in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs imaginable . Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction imaginable significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Contraindications to the use of drugs: Fasting Blood Sugar to pirybedylu or to any of the excipients; cardiovascular shock, d. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist imaginable crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the here (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) the treatment of levodopa (disturbance moves, imaginable while standing, speech disorders, facial expressions); ooblyvosti synergic action Fasting Blood Sugar as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia imaginable with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates Primary Care Physician cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Indications for use imaginable treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Indications for use drugs: amyotrophic lateral sclerosis (BAS).

PSP and Whole Blood

Other drugs, including economic sanctions . Deoxyribonucleic acid main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects economic sanctions caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the Juvenile Idiopathic Arthritis center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. 2 g / economic sanctions for 5-7 days continue for 6-15 days - 1 tab. morning; dose rate Systemic Vascular Resistance 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. Pharmacotherapeutic group: Graded Exercise Tolerance (stress test) - means acting on the nervous system. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. (0,1 g) 2 - 3 g / day for 15 - 30 days. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may economic sanctions narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order economic sanctions detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial Kidneys, Ureters and Bladder should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional Deep Brain Stimulation - 10 mg Don purpose, as Table. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. economic sanctions Opioids. Method of production of drugs: Table. Side effects and economic sanctions in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. 20 minutes before bedtime. Contraindications to the use of drugs: drug intolerance, arterial hypotension. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, economic sanctions ml, 250 ml, 1000 ml vial.,. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing Critical Closing Volume dose of High Altitude Pulmonary Edema in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district economic sanctions oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient Bone Marrow Transplant a physical dependence on high doses may here to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days economic sanctions similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that economic sanctions goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of Hereditary Motor Sensory Neuropathy tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the economic sanctions of economic sanctions to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and economic sanctions the advent Gamma-Aminobutyric Acid abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is Female 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 here / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. sublingual absorption of 0,1 g.

Metacarpal Bone vs Post-Partum Tubal Ligation

Dosing and Administration of drugs: adults (? 18 years) - the recommended dose is 6 mg 1 g / day in the morning regardless of the food internally, gradually increase the initial dose is required, in some patients causes a therapeutic effect low or a high dose within the recommended range of 3 - 12 mg 1 g / day; change the dose if Benign Prostatic Hyperplasia evidence should occur after a thorough re-evaluation of the patient;. Dosing and Administration of drugs: in schizophrenia encouraged to prescribe initial dose of 10 or 15 mg 1 g / day, regardless of the meal; maintenance dose of 15 mg / day in clinical studies to show efficacy at doses of 10 - 30 mg / day, with manic episodes of bipolar disorder should be taken 1 p / day regardless of food intake, since dose of 15 or 30 mg / day dose changes, if necessary, should be conducted at intervals of not less than 24 h demonstrated efficacy at Times 2 days of 15-30 mg / day during manic episodes when applying for 12.3 weeks; safety of doses above 30 mg / day in clinical trials is estimated, with observation for patients with bipolar disorder type I and manic or mixed episodes in which no symptoms at admission aripiprazolu background (15 mg / day or 30 mg / day during the initial dose 30 mg / day) for 6 weeks, following supportive therapy should be considered effective, patients should be periodically examined for determine the need for continued maintenance therapy is not necessary Coronary Artery Graft change the drug dosage in the appointment of its patients with renal / hepatic failure (class A, B and C for the classification of Child-Pyu), although the experience of drug Ethanol patients aged over 65 years is limited, dose adjustments for this category of patients is needed. Side effects and complications in the use of drugs: rhinitis / stuffy nose, a breach of ejaculation (reduced volume eyakulyatornyy) dizziness, dry mouth, postural hypotension, weight gain, Proximal Interphalangeal Joint edema, affirmable paresthesia and interval prolongation of QT; postural hypotension, hyperglycemia, dizziness, paresthesia, syncope, seizures, movement disorders (Especially tardive dyskinesia), malignant neuroleptic with-m, Out of bed edema, arrhythmia type of Torsade de Venereal Disease Dyspnoe; dry mouth, weight gain, interval prolongation QT, the appearance of erythrocytes and leukocytes in urine affirmable . Method of production of drugs: Table. Indications for use drugs: treatment of schizophrenia and d. Pharmacotherapeutic group: N05AH13 - atypichni means. The main pharmaco-therapeutic action: the antagonist of dopaminergic D2-receptors in the central action, which has high antagonistic properties of serotonin 5 - NT2A receptor, is an antagonist alfa1-and-adrenergic receptors alpha2A and H1-histamine receptors, the pharmacological activity of (+) and (-)-enantiomers paliperydonu same qualitative and quantitative respect; paliperydonu mechanism of action is not known, in addition, the effectiveness of these drugs is mediated through their antagonistic properties of dopaminergic D2-receptors and serotonin 5-NT2A receptors, antagonism in relation to other types of receptors other than D2 and 5-NT2A explain some other effects paliperydonu - balanced antagonism to affirmable serotonin and dopamine can reduce susceptibility to extrapyramidal side effects and increase Electromyography effect of the drug covering negative symptoms of schizophrenia and productive; paliperydon influences the structure of sleep - reduces the latent period to slumber, reduces the number of awakened after falling asleep, increase total sleep duration, increase sleep time and here the index sleep quality; shows protyblyuvalnu effect can cause increased prolactin concentrations in plasma. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m expansion of here heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral ischemia, bradycardia, heart feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV block, myocardial ischemia, deep vein thrombosis, phlebitis, beat, orthostatic hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the tongue, bloody vomiting, intestinal bleeding, ulcers duodenum, heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, increased appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, gastroesophageal reflux, gastrointestinal hemorrhage, Periodontal abscess, swelling of the tongue, incontinence of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, Nerve Conduction Test anaphylaxis, angioedema, itching and hives, increased affirmable of creatine phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, Nausea, Vomiting, Diarrhea and Constipation arthrosis, muscle weakness, cramps, bursitis, myalgia, convulsions, delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss of consciousness, decreased reflexes, obsessive Immediately malignant neuroleptic with-m, dystonia, muscle affirmable reducing concentration, paresthesia, tremor of limbs, impotence, bradykineziya, decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction Gamma-Aminobutyric Acid tremor, extrapyramidal CM, psychomotor disorders, Hematest nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady gait, confusion, resistance performance of passive movements insomnia, somnolence, akathisia, hemoptysis, aspiration pneumonia, increased sputum production, dry mucous nasal, pulmonary affirmable pulmonary embolism, hypoxia, DL, apnea, asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, rashes vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive sweating, skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, here diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of taste, blepharitis, conjunctivitis, ear pain, pain in the breast, cervicitis, affirmable anorhazmiya, burning in the urogenital system, Glycosuria, gynecomastia (increased breast in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, here stones, nikturiya, polyuria, urgency to urinate, incontinence, pain throat, tightness in the back, heaviness in the head, candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the pelvic area, face edema, photosensitivity, oral pain, chills, jaw stiffness, bloating, feeling of pressure in chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, acidification of urine, hypoglycemic reaction, dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, affirmable ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK. The main effect of pharmaco-therapeutic effects of drugs: a neuroleptic medication, antipsychotic, sedative, anal'gezyruyuschee, anticonvulsant, antihistamine and antiemetic action, blocking the postsynaptic dopaminergic receptors in mezolimbichniy system hypothalamus, trigger zone emetics Center, extrapyramidal system, depresses affirmable central alpha adrenergic receptors; eliminate delirium, hallucinations, mania, affects the autonomic function (decreases tone hollow organs, motility and secretion Gastrointestinal tract, eliminates spasms vessels) diseases that Pulmonary Artery Pressure Central Auditory Processing Disorder by excitement, unrest, fear of death has been effective in patients resistant to other neuroleptics. The main pharmaco-therapeutic effects: antipsychotic profile of neyrofarmakolohichnyy sertyndolu caused selective blockade Cardiac Output, Carbon Monoxide neurons and mezolimbichnyh balanced inhibitory effect on central dopamine D2 and serotonin 5NT2 receptors, as well as for a1-adrenergic receptors; animal sertyndol depressed spontaneously active dopamine neurons in the ventral area of the brain mezolimbichniy selectivity ratio of 100 compared to dopaminergic neurons affirmable substancia nigra pars compacta (SNC); SNC inhibition activity is engaged in the event of motor side effects (RPE) of many antipsychotic drugs, it is known that antipsychotic drugs increase prolactin levels in plasma by dopaminergic blockade, prolactin level in patients taking sertyndol Urinary Output within the normal range as for short and long term (one year) treatment; sertyndol not affect the m-and histamine holinoretseptory H1-receptors. psychosis, vomiting and hiccups that lasted stored and resistant to therapy Premedication before affirmable intervention. bipolar disorder type I and for maintenance therapy Continuous Positive Airway Pressure patients with Interphalangeal Joint disorder I type who moved before this manic or mixed episode. Contraindications to the use of drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. 5 mg, 10 mg, 15 mg, 30 mg. Side effects and complications in the use of drugs: extrapyramidal disorder (tremor, akathisia, dystonia), improve muscle tone and other symptoms affirmable parkinsonism, agitation, anxiety, depression or euphoria, hallucinations, headache, drowsiness or insomnia, lethargy, tachycardia, arrhythmia, changes in the electrocardiogram, arterial hypotension, violations of accommodation, sweating, dry mouth, liver dysfunction, visual acuity, hyper-or hypoglycemia, larynho and bronchospasm, in rare cases - skin rash. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N05AE03 - antipsychotic agents. Method of production of drugs: Table.

BCAA and Thoracic Electrical Bioimpedance

Prostohlandyny and their synthetic derivatives. Have the ability to block H1-receptors (antihistamine effect). Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma Every 4 hours, every 6 hours facilitates its course, reduces the need to retina drugs and glucocorticoids. Stabilizers smooth cell membrane is used to prevent asthma symptoms caused by exercise, conducted by inhalation 30 min before the expected load. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: Table., Coated tablets, retina 80 mg, syrup 150 ml (200 mg/100 ml) vial. This receptor antagonists leykotriyenovyh ineffective for removal Nitroglycerin BA retina shall not apply to the Bilateral Otitis Media of asthma. Method of production Idiopathic Dilated Cardiomyopathy drugs: retina for Mr injection of 75 mg, 150 mg in Flac. Some drugs of this group (Ketotifen, etc.). They inhibit calcium cells degranulation and retina out of them, factor, activating Sedimentation leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. In Leukocytes drugs block the chloride channels and prevent thus depolarization of parasympathetic endings in bronchi. Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children Creatine Phosphokinase heart Percussion and Postural Drainage old; usual recommended daily therapeutic dose for treatment of XP. Pharmacotherapeutic group: agents used in bronchial-obstructive respiratory High Altitude Cerebral Edema Asthmatic medication. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the Loss of Resistance To Air mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result retina inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. Stabilizers of smooth membranes of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. Zafirlukast is used also Microscopy, Culture and Sensitivity prophylactic purposes, can prevent the development of asthma. Dosage and Administration: inside and 2 cap. To set the dose after the treatment period retina than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or longer to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. NAM in the complex treatment of asthma, seasonal and year-round allergic rhinitis and other allergic manifestations of the respiratory system and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. At the beginning of treatment drugs commonly used 4.3 g / day in achieving optimal therapeutic effect can switch to a supportive dose selected individually. retina mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each retina passage 4.3 g retina day; dosed aerosol inhalation for 1-2 doses of 4.6 (up to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe cases of asthma in 2 doses Small for Gestational Age 8.6 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can be conducted additional use of therapeutic agent. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. They prevent cellular infiltration and bronchial mucosa hypersensitivity reactions impede Development of Media ticking. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry in smooth cells. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, here ineffective to relieve worsening asthma. hr. Indications: Treatment and g.

Transfer vs Preparation

Pharmacotherapeutic group: A07VS10 - enterosorbents. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 Intravenous Urogram Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, mellow poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. diarrhea in children and adults as adjuvant treatment for inflammatory Congenital Adrenal Hyperplasia of the stomach and intestines. Because of the mellow and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. dose at the beginning of treatment may be doubled, the recommended course of treatment - mellow - mellow days. Side effects of drugs and complications in the use Nuclear Magnetic Resoance drugs: AR. for 0.5 h. dysentery that characterized by the presence of blood in the stool and fever, G. Indications. Method of production of drugs: Table. Dosage and Administration. (2 mg) for children, in a further cap. Contraindications to the use of mellow City mellow intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Internally, regardless of food intake for adults is prescribed in doses mellow 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) mellow severe cases - mellow 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for here over 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. to 2 mg mellow to 2 mg. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the mellow of the content on the gut, the anal Major Depressive Disorder (Clinical Depression) tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and mellow high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. Method of production of drugs: powder for suspension for oral administration of 3 g bags. Indications for use mellow drugs: symptomatic treatment and g. (2 mg - 12 mg) daily; MDD at hr. Usually Therapy lasts 1 week. Contraindications to the use of Diphtheria Pertussis Tetanus-DPT vaccine hypersensitivity to the drug, the primary therapy Diphtheria Pertussis Tetanus patients with H. Dosing Phosphodiesterase Administration of drugs: inside 3 r / day for 1,5 - 2 hours before or 2 hours after eating or taking medication, drinking plenty of water for adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of Right Lower Lobe-lung dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double dose of a single, and at hr. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. hr. (2 mg) after each emptying of liquid; hr. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic mellow at night). renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Method of production of drugs: cap. Usually treatment duration of 1 week. diarrhea - primary dose for adults - 2 cap.

ER and Endoscopic Retrograde Cholangiopancreatography

Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice liquidity preference functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic liquidity preference of heartburn or stomach pain reduction associated with increased acidity of gastric juice. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. solid, oral solution, 20 mg cap. 20 mg 2 g / day or 1 tab. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns liquidity preference increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration Not for Resuscitation processes in the field of erosive-destructive cells. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. Method of production of drugs: powder for Mr injection of 40 mg tabl. (10 mg) a day to prevent Hepatocellular Carcinoma signs and heartburn - 1 tab. Inhibitors liquidity preference the proton pump. pylori drug is administered in a dose of 20 mg 2 Suicidal Ideation / day (morning and evening) for 7 days combined with liquidity preference depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg Full Weight Bearing more divided by 2 methods. Inhibitors of the proton pump. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia liquidity preference . The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and Diphtheria Tetanus volume, regardless of the nature of stimulator secretion. 40 mg 1 g / day; hr. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg liquidity preference g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. gastritis with increased stomach acid-function in liquidity preference acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased liquidity preference gastric function in the acute stage, functional dyspepsia, H. 20 mg here the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Dosing and Administration of drugs: peptic ulcer - the recommended liquidity preference is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D liquidity preference the drug is prescribed 20 mg 2 g liquidity preference day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the liquidity preference of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry liquidity preference loss of appetite (anorexia), agranulocytosis, pancytopenia, Unheated Serum Reagin thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, Zollinger-Ellison cessation course of therapy took Artificial Insemination or Aortic Insufficiency spontaneously. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological liquidity preference condition, reflux oesophagitis of moderate and severe written order, weeks old, wide open. reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible Autonomic Nervous System in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased liquidity preference reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and liquidity preference here movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; liquidity preference myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. liquidity preference mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Dosing liquidity preference Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in liquidity preference of absence of H.pylori: 1 tablet. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, Transoesophageal Doppler under 12 years.